<DOC>
	<DOCNO>NCT00002165</DOCNO>
	<brief_summary>To make nelfinavir mesylate ( Viracept ) available treatment HIV positive patient unable take three commercially available protease inhibitor ( failure , intolerance , contraindication ) CD4 cell count &lt; = 50 . To obtain additional information safety profile nelfinavir mesylate ( Viracept ) . ( PER AMENDMENT 1/8/97 : People qualify Viracept Program unable take indinavir and/or ritonavir due intolerance , contraindication prior failure . )</brief_summary>
	<brief_title>Viracept Expanded Access Program</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 T cell count &lt; = 100 cells/mm3 . Failed , intolerant contraindication three commercially available protease inhibitor ( saquinavir , indinavir ritonavir ) . ( PER AMENDMENT 1/8/97 : People qualify Viracept Program unable take indinavir and/or ritonavir due intolerance , contraindication prior failure . ) Exclusion Criteria Prior Medication : Excluded : Prior therapy Viracept . Required : Indinavir . Saquinavir . Ritonavir .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1996</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>CD4 Lymphocyte Count</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>